06824 -4- Pages Draft within 24 hrs
Name : Mr.X Age: 69 years Sex: Male DOB: 15-01-1950
Associated Diagnoses: None
Allergies : Nil Known allergies
VISIT SUMMARY
ADMISSION SUMMARY
Presenting Problems
Fever immunosuppressed pt
PRINCIPAL DIAGNOSIS
Pseudomonas sepsis
transfusion support for pancytopaenia post chemo
febrile neutropaenia
deconditioning requiring physio
bony pain
Mucositis
Past History and Co-morbidities: Not requiring changes to treatment
Pmhx
- Relapsed Multiple Myeloma ( t11,14), monosomy 13 and TP53 deletion -IgG kappa - initially diagnosed June 2014
Autologous stem cell transplant (ASCT on 14/1/15); on zometa 4mg, biochemical relapse 10 months post transplant - lenalidomide 25mg
Relapse end of July 2016 – CyBorD; relapsed 5/10/17
Start CYBORD 6/11/17 (Cyclophosphomide, Bortezomib and Dexamethasone)
Dex/Polamidamide from 7/12/17
- Hepatitis B core Ig positive
- T2 Diabetes Mellitus + steroid induced hyperglycaemia
- Steroid induced cataracts
- Repair of umbilical hernia 13/9/17
- Bells palsy right side
- Recent CNS plasmocytoma - On radiotherapy
Summary of Progress
Thankyou for your care of Mr.X who presented with fevers and sepsis
He was unwell with mouth ulcers and mucositis post recent PCAB chemotherapy. He was very lethargic with pancytopaenia. BLood cultures were positive for pseudomonas. He was treated with 7 days of tazocin and then deescalated to ciprofloxacin.
During the admission he complained of widespread bony pain, particularly left leg below knee. CT scan did not reveal any severe lytic lesion to explain pain below knee. Doppler US was negative for DVT.
CT chest revealed a large pleural based mass, most likely plasmacytoma as well as multiple lytic skeletal lesions.
He was commenced on targin with good effect.
Serum free kappa light chains were 500 which was reduced from 1000 previously.
He was very deconditioned and required several days of physiotherapy. He was mobilising with a walking stick on discharge.
Plan:
F/U with Haematologist
Continue analgesia with aperients
community pall care link on DC
Medications
Lamivudine 100mg daily
Ranitidaine 300mg daily
Bactrim Forte one tab daily
Gliclazide 60mg BD
Metformin 1g BD
Lipidil 145mg daily
Valaciclovir 500mg daily
Rosuvastatin 15mg daily
Candesartan 32/1.25mg daily
ADVERSE REACTIONS & ALERTS
Allergies
Allergic Reactions (Selected)
NKA
INTERVENTION & RESULTS
Procedures this Admission
Non Theatre Procedures
Procedure: Date:
Chest Routine CT
=========== REPORT TEXT ===========
CT Chest with Contrast
Performed on 02-JUL-2019, 09:51 AM
Clinical History: CH: 69 M ; background multiple myeloma, last chemo Friday 21/06; presented to ED yesterday with fevers and weakness; febrile to 38.8; CXR shows large rounded opacity right mid to lower zone ; ?extrapleural mass ; ?plasmocytoma ; ?other cause ; to furhter characterise with routine CT chest GCH: hypercholesterolemia; niguinal hernia :
Technique:
CT chest with IV contrast.
Comparison:
CT skeletal survey 27 March 2018
Findings:
The large pleural based lesion identified on the recent x-ray corresponds to a soft tissue lesion arising from and destroying the right 5th rib and measures approximately 7 x 4 x 6.6 cm (Se601;Im58). This represents marked interval progression of a likely myelomatous deposit identified on the previous CT skeletal survey.
Numerous other soft tissue skeletal destructive lesions are identified as below:
1. Right 2nd rib anteriorly 13x8mm - markedly decreased in size (36x21mm)
2. Right 3rd rib anteriorly 7mm - new, right 6th rib anteriorly - new, right 8th rib laterally 11mm -new, right 9th rib 12mm - new
3. Right 11th rib - posteriorly - stable.
4. Left 4th rib two foci of soft tissue - new, left 5th rib anteriorly 10mm - new, left 6th anteriorly - new, left 7th posteriorly, 8th rib multiple foci, 9th rib multiple foci - new
New soft tissue lesion at the left lamina and pedicle of the T3 vertebral body (Se601;Im14).
There is early encroachment upon the left posterolateral spinal canal and adjacent 90 degrees contact of the left thecal sac.
Spinal canal is preserved in the reminader of the visualized aspects thoracic spine.
T8 right-sided vertebral body soft tissue deposit with infiltration of the right neural exit foramen (series 603; image 53) - progressed since previous imaging.
Significant interval progression of the soft tissue lesion affecting the sternum with deformity and depression toward the anterior mediastinum.
Numerous well-defined lytic lesions are identified throughout the thoracic spine - mild interval progression.
Left scapula deposit has increased in size. Right scapula appearance is unchanged.
Numerous foci of old fractures and endosteal scalloping in keeping with marrow change is noted.
Pulmonary arteries are patent.
No pericardial effusion.
No thoracic lymphadenopathy.
Small calcified granuloma in the inferior aspect of the left upper lobe.
Bibasal atelectatic bands are noted.
Small bilateral pleural effusions with overlying atelectasis.
Partially visualised upper abdomen and pelvis are within normal limits.
Conclusion:
1. Pleural based lesion identified on the recent chest X-ray is representative of significant interval enlargement of a previously noted myelomatous deposit.
2. Significant interval progression of multifocal thoracic cage and axial skeletal lesions.
3. Please correlate clinically for any radiculopathy regarding the left T3 and right T8 thoracic vertebral deposits which encroach upon the spinal canal and neural exit foramen respectively.
Results
|
10-07-2019 08:20 |
Sodium |
134 mmol/L LOW |
|
|
Potassium |
4.4 mmol/L |
|
|
Chloride |
99 mmol/L |
|
|
Bicarbonate |
22 mmol/L |
|
|
Urea |
2.4 mmol/L LOW |
|
|
Creatinine |
93 µmol/L |
|
|
Estimated GFR |
72 mL/min/1.73m² |
|
|
Bilirubin Total |
10 µmol/L |
|
|
Albumin |
32 g/L LOW |
|
|
Protein |
57 g/L LOW |
|
|
ALP |
65 U/L |
|
|
Gamma GT |
146 U/L HI |
|
|
ALT |
22 U/L |
|
|
AST |
13 U/L |
|
|
Lact. Dehydrogenase |
203 U/L |
|
|
Calcium |
2.35 mmol/L |
|
|
Corrected Calcium |
2.51 mmol/L |
|
|
Magnesium |
0.66 mmol/L LOW |
|
|
Phosphate |
0.96 mmol/L |
|
|
WCC |
5.7 x10^9/L |
|
|
HB |
90 g/L LOW |
|
|
PLT |
99 x10^9/L LOW |
|
|
PCV |
0.25 L/L LOW |
|
|
MCV |
94.5 fL |
|
|
RCC |
2.69 x10^12/L LOW |
|
|
MCH |
33.5 pg HI |
|
|
MCHC |
355 g/L |
|
|
RDW |
16.8 % HI |
|
|
Neutrophils |
4.2 x10^9/L |
|
|
Lymphocytes |
0.8 x10^9/L LOW |
|
|
Monocytes |
0.7 x10^9/L |
|
|
Eosinophils |
0.1 x10^9/L |
|
|
Basophils |
0.0 x10^9/L |
|
|
Poikilocytes |
+ |
|
|
Polychromasia |
++ |
|
|
Tear Drops |
Occasional |
|
|
Target Cells |
+ |
|
|
Rouleaux |
+ |
|
|
Blood Film |
Blood Film Review |
|
|
Film Examined? |
Yes |
|
|
PT |
14.7 sec |
|
|
APTT |
30 sec |
|
|
INR |
1.1 |
Pending Results
_Antibody Comment - 10/07/2019
_POSITIVE ANTIBODY SCREEN - 10/07/2019
Contact Numbers for Diagnostic Departments:
CONTINUED CARE RECOMMENDATIONS
Follow up Requirements for:
Outpatient Clinic Appointments
Appointments
.
Person to contact regarding this Discharge:
(Trainee Specialist) : Position Registrar.